Abstract
The benefits and safety of intravenous recombinant tissue plasminogen activator (IV-tPA) for patients with mild ischaemic stroke (MIS) are still unclear. The objective of this meta-analysis was to evaluate the...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have